Changzhou First People's Hospital, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.
Changzhou First People's Hospital, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.
J Surg Res. 2019 Feb;234:269-276. doi: 10.1016/j.jss.2018.09.025. Epub 2018 Oct 16.
Preliminary study on the feasibility and efficacy of laparoscopic cholecystectomy and radical cholecystectomy in stage Tis-T3 gallbladder cancer (GBC).
Retrospective analysis of the clinical data of 102 patients with GBC from August 2008 to August 2017 in the Department of Hepatopancreatobiliary Surgery at the Third Affiliated Hospital of Soochow University. The clinical and pathological data of laparoscopic surgery and open surgery were compared.
Of 102 patients with GBC, 41 underwent laparoscopic treatment, 12 of whom underwent laparoscopic cholecystectomy, and the others underwent laparoscopic radical cholecystectomy/extended radical cholecystectomy. Sixty-one patients underwent radical cholecystectomy/extended radical cholecystectomy. Based on the individual patient's condition, excision of the extrahepatic biliary tract and cholangioenterostomy were performed. There were no perioperative deaths. There was no significant difference in the operative blood loss (P = 0.732), operative time (P = 0.058), postoperative complications (P = 0.933), R0 margins (P = 0.679), and tumor-related death (P = 0.396) between the laparoscopic group and the laparotomy group. The postoperative activity time (P < 0.001), postoperative eating time (P < 0.001), drainage tube removal time (P < 0.001), and postoperative hospital discharge time (P < 0.001) in the laparoscopic group were all earlier than those in the laparotomy group, and the difference was statistically significant. The number of lymph nodes resected in the laparoscopic group and the laparotomy group was 1-17, average (5 ± 3) and 1-13 average (5 ± 3), respectively, with no statistically significant difference (P = 0.973). The 1-, 3-, and 5-y survival rates in the laparoscopic group were 97.1%, 69.4%, and 51.9%, respectively, and those in the laparotomy group were 94.7%, 64.9%, and 55.7%, respectively; there were no significant difference between the two groups (P = 0.453). In terms of different pathologic T stages, the 5-y survival rates of patients with stage Tis (9 cases), T1a (2 cases), T1b (8 cases), T2 (14 cases), and T3 (8 cases) disease in the laparoscopic group were 100%, 100%, 75%, 48.1%, and 12.5%, respectively, and the 5-y survival rates in patients with stage Tis (4 cases), T1b (9 cases), T2 (32 cases), and T3 (16 cases) disease in the laparotomy group were 100%, 87.5%, 64.7%, and 16%, respectively; there were no significant differences between the two groups.
Laparoscopic treatment of stage Tis-T3 GBC is feasible. Laparoscopic treatment of GBC does not increase the incision metastasis rate on the basis of the intact gallbladder wall. The same survival rates can be achieved with laparoscopic treatment as with open treatment of GBC. In terms of postoperative rehabilitation, laparoscopic treatment has more advantages.
初步研究腹腔镜胆囊切除术和根治性胆囊切除术在Tis-T3 期胆囊癌(GBC)中的可行性和疗效。
回顾性分析 2008 年 8 月至 2017 年 8 月苏州大学附属第三医院肝胆胰外科 102 例 GBC 患者的临床资料。比较腹腔镜手术和开腹手术的临床病理资料。
102 例 GBC 患者中,41 例行腹腔镜治疗,其中 12 例行腹腔镜胆囊切除术,其余行腹腔镜根治性胆囊切除术/扩大根治性胆囊切除术。61 例患者行根治性胆囊切除术/扩大根治性胆囊切除术。根据患者个体情况,行肝外胆管切除和胆肠吻合术。无围手术期死亡。腹腔镜组与剖腹组在术中出血量(P=0.732)、手术时间(P=0.058)、术后并发症(P=0.933)、R0 切缘(P=0.679)和肿瘤相关死亡(P=0.396)方面差异无统计学意义。腹腔镜组术后活动时间(P<0.001)、术后进食时间(P<0.001)、引流管拔除时间(P<0.001)和术后出院时间(P<0.001)均早于剖腹组,差异有统计学意义。腹腔镜组和剖腹组淋巴结清扫数量分别为 1-17 枚,平均(5±3)枚和 1-13 枚,平均(5±3)枚,差异无统计学意义(P=0.973)。腹腔镜组的 1、3、5 年生存率分别为 97.1%、69.4%和 51.9%,剖腹组分别为 94.7%、64.9%和 55.7%;两组差异无统计学意义(P=0.453)。在不同病理 T 分期方面,Tis 期(9 例)、T1a 期(2 例)、T1b 期(8 例)、T2 期(14 例)和 T3 期(8 例)患者的腹腔镜组 5 年生存率分别为 100%、100%、75%、48.1%和 12.5%,Tis 期(4 例)、T1b 期(9 例)、T2 期(32 例)和 T3 期(16 例)患者的剖腹组 5 年生存率分别为 100%、87.5%、64.7%和 16%,两组差异无统计学意义。
腹腔镜治疗Tis-T3 期 GBC 是可行的。在保留胆囊壁完整的基础上,腹腔镜治疗 GBC 不会增加切口转移率。腹腔镜治疗与开腹治疗 GBC 可获得相同的生存率。在术后康复方面,腹腔镜治疗具有更多优势。